Nasal spray biotech Firebrick skyrockets in market debut
 MELBOURNE: Shares in Firebrick Pharma, which is developing a nasal spray to treat the common
            
            MELBOURNE: Shares in Firebrick Pharma, which is developing a nasal spray to treat the common					
				    
         MELBOURNE: Shares in Firebrick Pharma, which is developing a nasal spray to treat the common
            
            MELBOURNE: Shares in Firebrick Pharma, which is developing a nasal spray to treat the common